COVID-19 vaccination rates vary by community vulnerability: A county-level analysis.
Vaccine. 2021 07 13; 39(31):4245-4249.V

Abstract

We used the COVID-19 Community Vulnerability Index and 7 theme scores to assess associations between vulnerability and county-level COVID-19 vaccination (n = 2415 counties) through May 25th, 2021. When comparing vaccination rates among quintiles of CCVI scores, Theme 3 (housing type, transportation, household composition, and disability) was associated with the largest disparity, with the least vulnerable counties (Q1) having 33% higher rates of vaccination among individuals aged 18+ (53.5% vs 40.2%) compared to counties with the highest vulnerability (Q5). Using generalized linear models with binomial distributions and log links, we found that a 10-point increase in the CCVI index, socioeconomic vulnerability, housing type and composition, and epidemiological factors were associated with at least a 1.0 percentage point decline in county-level vaccination. The association between community vulnerability and lower vaccination rates suggests the need for continued efforts for equitable COVID-19 vaccination across marginalized communities.

Links

Publisher Full Text
ncbi.nlm.nih.gov
linkinghub.elsevier.com
PMC Free PDF
Aggregator Full Text

Authors+Show Affiliations

Brown CC
Department of Health Policy and Management, University of Arkansas for Medical Sciences, Fay W Boozman College of Public Health, 4301 West Markham Slot #820, Little Rock, AR 72205, United States. Electronic address: cbrown3@uams.edu.
Young SG
Department of Environmental and Occupational Health, University of Arkansas for Medical Sciences, Fay W Boozman College of Public Health, 4301 West Markham Slot #820, Little Rock, AR 72205, United States. Electronic address: SGYoung@uams.edu.
Pro GC
Department of Health Behavior and Health Education, University of Arkansas for Medical Sciences, Fay W Boozman College of Public Health, 4301 West Markham Slot #820, Little Rock, AR 72205, United States. Electronic address: GCPro@uams.edu.

MeSH

COVID-19COVID-19 VaccinesHumansSARS-CoV-2United StatesVaccination

Pub Type(s)

Journal Article

Language

eng

PubMed ID

34167838